| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/04/2004 | CN1160113C Medicine and food dual-purpose enriched nutrient for resisting AIDS |
| 08/04/2004 | CN1160112C Therapeutic liquid for common cold and rhinits and its preparing method and use |
| 08/04/2004 | CN1160109C Medicine for treating wind-heat type common cold and its preparing process |
| 08/04/2004 | CN1160104C Traditional chinese medicine compostion with blood-enrich, tonifying Qi and warming kidney function |
| 08/04/2004 | CN1160102C Chinese medicine for curing female chronic inflammation |
| 08/04/2004 | CN1160083C Medicine for treating osteomyelitis and lymphoid tuberculosis, and making process thereof |
| 08/04/2004 | CN1160081C Combination therapy of HIV infection using HIV protease inhibitior induinavir and reverse transcriptase inhibitor 3TC, optionally together with AZT, DDI or DDC |
| 08/04/2004 | CN1160078C sialic acid, its salt, pharmaceutical use of its polymer or salt of polymer |
| 08/04/2004 | CN1160077C External-used medicine containing phosphonomycin calcium and its application |
| 08/04/2004 | CN1160069C Palladium-substd. bacteriochlorophll derivatives and use thereof |
| 08/04/2004 | CN1160064C Selective antibiotic composition |
| 08/04/2004 | CN1160056C Intravaginal clindamycin ovule composition |
| 08/04/2004 | CN1160055C External-use bathing lotion with antibiotic and anti-inflammatory functions |
| 08/04/2004 | CN1159999C Healthy shoes of konjaku |
| 08/03/2004 | US6770664 Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods |
| 08/03/2004 | US6770656 Amine derivatives for the treatment of apoptosis |
| 08/03/2004 | US6770652 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same |
| 08/03/2004 | US6770644 Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient |
| 08/03/2004 | US6770621 Polyacid glycopeptide derivatives |
| 08/03/2004 | US6770595 Cyclic imines as pesticides |
| 08/03/2004 | US6770290 Amphotericin b liposomes formed have markedly reduced toxicity |
| 08/03/2004 | US6770267 Methods of treating periodontal disease |
| 08/03/2004 | CA2160696C Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 08/03/2004 | CA2147753C Tropone-substituted phenyloxazolidinone antibacterial agents |
| 08/03/2004 | CA2144317C Hepatitis a virus vaccines |
| 08/03/2004 | CA2133079C Oxazolidinone antimicrobials containing substituted diazine moieties |
| 08/03/2004 | CA2125001C Process for converting loracarbef dihydrate to loracarbef monohydrate |
| 08/03/2004 | CA2070230C Crystalline oxathiolane derivatives |
| 07/29/2004 | WO2004063748A1 Method of screening agonist or antagonist to thyroxine receptor |
| 07/29/2004 | WO2004063374A1 HPV-E6-SPECIFIC siRNAs FOR THE TREATMENT OF HPV-RELATED TUMORS |
| 07/29/2004 | WO2004063363A1 Different dendritic cell subsets |
| 07/29/2004 | WO2004063336A2 Uses of deazapurines for the treatment of reperfusion injuries, osteoporosis and/or bone metastasis |
| 07/29/2004 | WO2004063197A1 Pyrrolopyridazine derivatives |
| 07/29/2004 | WO2004063181A1 Urea derivatives and their use as anti-inflammatory agents |
| 07/29/2004 | WO2004063160A1 Novel quaternary ammonium salt compound having antibacterial activity and process for producing the same |
| 07/29/2004 | WO2004062691A1 Agent improving proton-driven transporter-mediated absorption in digestive tract and process for producing the same |
| 07/29/2004 | WO2004062686A2 Therapeutic use of modulators of notch |
| 07/29/2004 | WO2004062679A1 Zanthoxylum spp. plant extracts for treating aids |
| 07/29/2004 | WO2004062677A1 Bacteriophage for the treatment of bacterial biofilms |
| 07/29/2004 | WO2004062676A1 -modified nucleoside derivatives for treating flaviviridae infections |
| 07/29/2004 | WO2004062674A2 Substituted polyamines as inhibitors of bacterial efflux pumps |
| 07/29/2004 | WO2004062658A1 A method of treatment or prophylaxis of symptoms of herpes viral infection |
| 07/29/2004 | WO2004062645A1 Microspheres containing amphotericin b |
| 07/29/2004 | WO2004062597A2 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 07/29/2004 | WO2004062592A2 2-o sulfatase compositions and related methods |
| 07/29/2004 | WO2004062551A2 RECOMBINANT VHH SINGLE DOMAIN ANTIBODY FROM CAMELIDAE AGAINST VON WILLEBRAND FACTOR (vWF) OR AGAINST COLLAGEN |
| 07/29/2004 | WO2004050086A8 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 07/29/2004 | WO2004045533A3 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 07/29/2004 | WO2004037173A3 Method for treating erectile dysfunction and increasing libido in men |
| 07/29/2004 | WO2004035590A3 Meso-substituted porphyrins |
| 07/29/2004 | WO2004024889A3 Production of bispecific molecules using polyethylene glycol linkers |
| 07/29/2004 | WO2004019910A3 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 07/29/2004 | WO2004014913A3 Derivatives of 2-trifluormethyl-6-aminopurine as phosphodiesterase 4 inhibitors |
| 07/29/2004 | WO2004010972A3 Pellicle-resistant gelatin capsule |
| 07/29/2004 | WO2004000873A3 Adjuvant-free peptide vaccine |
| 07/29/2004 | WO2003101382A3 Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 07/29/2004 | WO2003094850A3 Lipid a and other carbohydrate ligand analogs |
| 07/29/2004 | WO2003078367A3 Benzyl alcohol derivatives and their use as antimicrobial agents |
| 07/29/2004 | WO2003040369A3 Sequences involved in tumoral suppression, tumoral reversion, apoptosis and/or viral resistance phenomena and their use as medicines |
| 07/29/2004 | WO2003028634A8 Method of treatment using ligand-immunogen conjugates |
| 07/29/2004 | WO2003011209A3 Methods of sensitizing hepatocyte cell cultures to hepatitis infection, beads coated with hbv or hcv polypeptides and methods of using such beads to model viral infection or deliver substances into hepatocytes |
| 07/29/2004 | WO2003003941A3 One dose vaccination with mycoplasma hyopneumoniae |
| 07/29/2004 | US20040147788 Stilbene derivatives and their use as aryl hydrocarbon receptor antagonistic ligands |
| 07/29/2004 | US20040147739 Novel anti-infectives |
| 07/29/2004 | US20040147724 for diagnosis/treatment of cancer, myeloproliferative disorders, angiogenesis, obesity, osteoporosis, non-insulin dependent diabetes, lipid metabolism disorder, hypercalcemia, hypercholestrolemia; genetic engineering |
| 07/29/2004 | US20040147723 Moringa seed proteins |
| 07/29/2004 | US20040147603 Malic acid addition salts of terbinafine |
| 07/29/2004 | US20040147600 Mixture of drug with insulin; antidiabetic agents |
| 07/29/2004 | US20040147599 Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors |
| 07/29/2004 | US20040147595 Biofilm degrading or sloughing compositions and methods |
| 07/29/2004 | US20040147591 Viricides; anticancer agents; immunostimulant |
| 07/29/2004 | US20040147587 Compounds for the modulation of the glycolysis enzyme and/or transaminase complex |
| 07/29/2004 | US20040147580 Therapy for bacteria infections |
| 07/29/2004 | US20040147578 Use of lipoaminoacids as absorption promoters in a pharmaceutical composition |
| 07/29/2004 | US20040147562 Controlling cell gene expression; moderate cell proliferation; anticancer agents; antiinflammatory agents; cardiovascular disorders; autoimmune disease |
| 07/29/2004 | US20040147558 Synthesis of 3-amino-thalidomide and its enantiomers |
| 07/29/2004 | US20040147556 Analgesics; anxiolytuic agents; gastrointestinal disorders |
| 07/29/2004 | US20040147549 Antiviral compounds |
| 07/29/2004 | US20040147548 2-NH-heteroarylimidazoles with antibacterial activity |
| 07/29/2004 | US20040147547 HIV-integrase inhibitors, pharmaceutical compositions, and methods for their use |
| 07/29/2004 | US20040147546 Heterocyclic compounds |
| 07/29/2004 | US20040147545 Therapy for infection |
| 07/29/2004 | US20040147536 Remedies for sepsis |
| 07/29/2004 | US20040147525 Antiinflammatory agents; analgesics; antiarthritic agents |
| 07/29/2004 | US20040147512 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 07/29/2004 | US20040147508 Biologically active methylene blue derivatives |
| 07/29/2004 | US20040147500 Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same |
| 07/29/2004 | US20040147490 Immunosuppressants |
| 07/29/2004 | US20040147476 For therapy and prophylaxis of virus infections, other pathogenic infections or cancers |
| 07/29/2004 | US20040147468 Immunostimulatory nucleic acid molecules |
| 07/29/2004 | US20040147464 For therapy |
| 07/29/2004 | US20040147435 Compositions and methods for importing biologically active molecules into cells and for treating inflammation |
| 07/29/2004 | US20040147431 Erythropoietin composition |
| 07/29/2004 | US20040147010 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potential pathogenic gram-positive bacteria |
| 07/29/2004 | US20040146994 Glycosaminoglycans derived from the k5 polysaccharide having high anticoagulant and antithrombotic activity and process for their preparation |
| 07/29/2004 | US20040146933 Latent human tuberculosis model, diagnostic antigens, and methods of use |
| 07/29/2004 | US20040146853 Methods for drug discovery, disease treatment, and diagnosis using metabolomics |
| 07/29/2004 | US20040146534 Vaccine for transcutaneous immunization |
| 07/29/2004 | US20040146528 MVA expressing modified HIV envelope, gag, and pol genes |
| 07/29/2004 | US20040146522 For therapy of individual exposed to or infected with HIV-1 |